Aptamer‐Based Approaches in the Selective Targeting of Biomarkers for Gene Silencing in Various Cancers
Advances in Pharmacological and Pharmaceutical Sciences · 2026-01 · 2026 (1)
DOI: 10.1155/adpp/5582390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Pharmacological and Pharmaceutical Sciences, online erschienen am 17.11.2026. Verfasst von Sivuyile Sikanise und 3 weiteren Autor:innen. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer continues to place a huge health burden on the world’s population because most of the genes expressed in cancer cells contribute greatly to the rapid development, proliferation, drug resistance and survival of cancerous cells in the body. Over the years, new therapeutic approaches, which involve the use of various agents to silence genes, are being explored. RNA interference is the current widely used gene silencing method; however, it is associated with challenges such as poor membrane penetration and susceptibility to degradation by nucleases in vivo. Recently, aptamers have evolved as a promising alternative in oncotherapy for gene silencing. Aptamers are short, single‐stranded oligonucleotides that specifically bind to target molecules with high binding affinity, and they can be modified to increase their stability. These properties make aptamers well‐suited for cancer gene silencing. Several studies have successfully used aptamers for gene silencing using approaches such as aptamer–drug conjugates and aptamer–nanoparticles. This review provides an overview of aptamer‐based approaches for gene silencing in various types of cancer. The various studies that employed gene silencing were carefully and critically analysed and summarized to critically provide further insight into the utility and effectiveness of aptamers in gene silencing. In addition, this review further provides information on the challenges and limitations of these approaches. The future perspectives and implications of aptamer‐mediated approaches in gene silencing in cancer are also discussed. The findings from the studies show that aptamers are promising agents in gene silencing for potential enhanced therapeutic efficacy in cancer treatment.
Zitieren
APA
Sikanise, S., Santos, P., Fasiku, V., & Sekhoacha, M. (2026). Aptamer‐Based Approaches in the Selective Targeting of Biomarkers for Gene Silencing in Various Cancers. Advances in Pharmacological and Pharmaceutical Sciences, 2026(1). https://doi.org/10.1155/adpp/5582390
Vancouver
Sikanise S, Santos P, Fasiku V, Sekhoacha M. Aptamer‐Based Approaches in the Selective Targeting of Biomarkers for Gene Silencing in Various Cancers. Advances in Pharmacological and Pharmaceutical Sciences. 2026;2026(1). doi:10.1155/adpp/5582390
BibTeX
@article{Sikanise2026,
author = {Sikanise, Sivuyile and Santos, Paul and Fasiku, Victoria and Sekhoacha, Mamello},
title = {Aptamer‐Based Approaches in the Selective Targeting of Biomarkers for Gene Silencing in Various Cancers},
journal = {Advances in Pharmacological and Pharmaceutical Sciences},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/adpp/5582390}
}
EUVIMED